Results 231 to 240 of about 37,555 (294)
American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, Volume 201, Issue 4, Page 257-269, June 2026.ABSTRACT A comprehensive synthesis of the broad range of neurodevelopmental and psychiatric manifestations in NF1 is needed to identify knowledge gaps and future directions for NF1 research. In the following scoping review, we identify and summarize the scope of research that examines neurodevelopmental and psychiatric manifestations, both as ...
Meera Chopra +5 more
wiley +1 more source
Brain and Behavior, Volume 16, Issue 6, June 2026.Preliminary Psychometric Properties of Panic Disorder Severity Scale ‐ Self‐Report Version: Validity, Reliability, and the Cutoff point in Persian Clinical Samples METHOD & PARTICIPANTS (Iranian Sample, N = 63) PDSS‐SR Self‐Report Scale Administration • Clinical Group (PD) (N = 45; 75.6% female) • Comparison Group (non‐PD) (N = 18; 83.3% female ...
Fatemeh Akhavan‐Abiri +3 more
wiley +1 more source
Caffeine and Headache: Exploring the Multifaceted Relationship
Brain and Behavior, Volume 16, Issue 6, June 2026.ABSTRACT Purpose To explore the multifaceted relationship between caffeine and headache disorders, focusing on its dual role as both an analgesic and a potential trigger and to summarize the mechanisms underlying its anti‐nociceptive effects. Method This narrative review synthesizes evidence from experimental, clinical, and epidemiological studies on ...
Mona Hussein +6 more
wiley +1 more source
Subterranean environments contribute to three‐quarters of classified ecosystem services
Biological Reviews, Volume 101, Issue 3, Page 1582-1605, June 2026.ABSTRACT Beneath the Earth's surface lies a network of interconnected caves, voids, and systems of fissures forming in rocks of sedimentary, igneous, or metamorphic origin. Although largely inaccessible to humans, this hidden realm supports and regulates services critical to ecological health and human well‐being.
Stefano Mammola +30 more
wiley +1 more source
La Revue du praticien, 2009 Social phobia is a relatively unrecognized disease. This ignorance is partly due to border troubles, as timidity, troubles between the norm and the pathologic, between psychiatry, psychology and sociology. Many other disorders appear to be differential diagnosis and question about nosographic limits of social phobia.
Grégory, Thomas, Vonsy, Herenui
core +5 more sources
Behavior Modification, 2000 A greater understanding of the origins of social phobia is much needed. The research to date is limited by the relatively small number of studies that sample clinical populations of individuals with social phobia. There is, however, research derived from related areas such as shyness, social anxiety, self-consciousness, peer neglect, and social ...
J L, Hudson, R M, Rapee
openaire +3 more sources
Information-processing bias in social phobia
Clinical Psychology Review, 2004 Social phobia is a persistent disorder that is unlikely to be maintained by avoidance alone. One reason for the enduring nature of social phobia may be the way individuals with the disorder process social information.
Colette R Hirsch, David M Clark
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
The Journal of Clinical Psychiatry, 1996
Several open trials suggest the efficacy of the selective serotonin reuptake inhibitors (SSRIs) in social phobia. This study attempted to assess the efficacy of paroxetine, a new SSRI, in the treatment of social phobia.Paroxetine was administered to 18 patients who had a primary DSM-III-R diagnosis of social phobia, generalized type (diagnosed by using
C, Mancini, M V, Ameringen
openaire +2 more sources
Several open trials suggest the efficacy of the selective serotonin reuptake inhibitors (SSRIs) in social phobia. This study attempted to assess the efficacy of paroxetine, a new SSRI, in the treatment of social phobia.Paroxetine was administered to 18 patients who had a primary DSM-III-R diagnosis of social phobia, generalized type (diagnosed by using
C, Mancini, M V, Ameringen
openaire +2 more sources
Journal of Affective Disorders, 1994
Twenty-two patients meeting a primary DSM-III-R diagnosis of Social Phobia, entered a 12 week open trial of sertraline. Twenty patients completed at least 8 weeks of treatment. Sixteen patients (80%) were considered responders and 4 (20%) were considered non-responders.
M, Van Ameringen +2 more
openaire +4 more sources
Twenty-two patients meeting a primary DSM-III-R diagnosis of Social Phobia, entered a 12 week open trial of sertraline. Twenty patients completed at least 8 weeks of treatment. Sixteen patients (80%) were considered responders and 4 (20%) were considered non-responders.
M, Van Ameringen +2 more
openaire +4 more sources
Journal of Clinical Psychopharmacology, 1986
Phenelzine was administered to 11 patients meeting DSM-III criteria for social phobia in open clinical trials. Seven of 11 showed marked improvement, while the remaining four experienced moderate benefit. These findings, which require replication in controlled trials, suggest that in addition to other actions, phenelzine has a direct effect in reducing
M R, Liebowitz +4 more
openaire +2 more sources
Phenelzine was administered to 11 patients meeting DSM-III criteria for social phobia in open clinical trials. Seven of 11 showed marked improvement, while the remaining four experienced moderate benefit. These findings, which require replication in controlled trials, suggest that in addition to other actions, phenelzine has a direct effect in reducing
M R, Liebowitz +4 more
openaire +2 more sources